Return to homepagePandemic Pact

Development of a vaccine, MVACOVID-19, expressing SARS-COV2 antigens

  • Funded by Centro Regulador de Urgencias y Emergencias (CRUE Santander)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $228,000

  • Funder

    Centro Regulador de Urgencias y Emergencias (CRUE Santander)

  • Research Location

    Spain

  • Lead Research Institution

    CSIC

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract